159 related articles for article (PubMed ID: 7638126)
1. [Skin, a privileged target for gene therapy].
Descamps V
Presse Med; 1995 May; 24(19):882-4. PubMed ID: 7638126
[TBL] [Abstract][Full Text] [Related]
2. The genodermatoses: candidate diseases for gene therapy.
Uitto J; Pulkkinen L
Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
[TBL] [Abstract][Full Text] [Related]
3. Regulated cutaneous gene delivery: the skin as a bioreactor.
Cao T; Wang XJ; Roop DR
Hum Gene Ther; 2000 Nov; 11(16):2297-300. PubMed ID: 11084689
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery to the epidermis.
Trainer AH; Alexander MY
Hum Mol Genet; 1997; 6(10):1761-7. PubMed ID: 9300669
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
Braun-Falco M; Eisenried A; Büning H; Ring J
Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
[TBL] [Abstract][Full Text] [Related]
6. Host immune responses in ex vivo approaches to cutaneous gene therapy targeted to keratinocytes.
Lu Z; Ghazizadeh S
Exp Dermatol; 2005 Oct; 14(10):727-35. PubMed ID: 16176280
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous gene transfer and therapy: the present and the future.
Spirito F; Meneguzzi G; Danos O; Mezzina M
J Gene Med; 2001; 3(1):21-31. PubMed ID: 11269332
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study.
Kang WK; Park C; Yoon HL; Kim WS; Yoon SS; Lee MH; Park K; Kim K; Jeong HS; Kim JA; Nam SJ; Yang JH; Son YI; Baek CH; Han J; Ree HJ; Lee ES; Kim SH; Kim DW; Ahn YC; Huh SJ; Choe YH; Lee JH; Park MH; Kong GS; Park EY; Kang YK; Bang YJ; Paik NS; Lee SN; Kim SH; Kim S; Robbins PD; Tahara H; Lotze MT; Park CH
Hum Gene Ther; 2001 Apr; 12(6):671-84. PubMed ID: 11426466
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts and dermal gene therapy: a minireview.
Krueger GG
Hum Gene Ther; 2000 Nov; 11(16):2289-96. PubMed ID: 11084688
[TBL] [Abstract][Full Text] [Related]
10. Genetic correction of inherited epidermal disorders.
Khavari PA
Hum Gene Ther; 2000 Nov; 11(16):2277-82. PubMed ID: 11084686
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous gene therapy--an update.
Christensen R; Jensen UB; Jensen TG
Histochem Cell Biol; 2001 Jan; 115(1):73-82. PubMed ID: 11219611
[TBL] [Abstract][Full Text] [Related]
12. [Skin and gene therapy. Hopes and realities].
Descamps V
Ann Dermatol Venereol; 1995; 122(4):226-34. PubMed ID: 8526417
[TBL] [Abstract][Full Text] [Related]
13. An approach to achieve long-term expression in skin gene therapy.
Therrien JP; Pfützner W; Vogel JC
Toxicol Pathol; 2008 Jan; 36(1):104-11. PubMed ID: 18337228
[TBL] [Abstract][Full Text] [Related]
14. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
15. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.
Stoff A; Rivera AA; Banerjee NS; Mathis JM; Espinosa-de-los-Monteros A; Le LP; De la Torre JI; Vasconez LO; Broker TR; Richter DF; Stoff-Khalili MA; Curiel DT
Wound Repair Regen; 2006; 14(5):608-17. PubMed ID: 17014674
[TBL] [Abstract][Full Text] [Related]
16. Keratinocyte gene therapy.
Vogel JC
Arch Dermatol; 1993 Nov; 129(11):1478-83. PubMed ID: 8239704
[TBL] [Abstract][Full Text] [Related]
17. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
18. The production and applications of genetically modified skin cells.
Bevan S; Martin R; Mckay IA
Biotechnol Genet Eng Rev; 1999; 16():231-56. PubMed ID: 10819081
[No Abstract] [Full Text] [Related]
19. Advances in gene therapy for malignant melanoma.
Sotomayor MG; Yu H; Antonia S; Sotomayor EM; Pardoll DM
Cancer Control; 2002; 9(1):39-48. PubMed ID: 11907465
[TBL] [Abstract][Full Text] [Related]
20. [Gene therapy and the skin].
Hengge UR; Bardenheuer W; Doroudi R; Mirmohammadsadegh A
Ann Dermatol Venereol; 2005 Feb; 132(2):154-63. PubMed ID: 15798569
[No Abstract] [Full Text] [Related]
[Next] [New Search]
